Signup/Login
If you want to receive notifications of upcoming IPOs, you need to simply sign up or sign in with social networks.
Signup/Login
Can you determine which companies are good and which ones - the trash?
Free Pro-version
IPO Filter
Monitor
IPO today
Upcoming IPO
Biofrontera (BFRI)
Marpai (MRAI)
Cingulate, Inc. (CING)
Stronghold Digital Mining, Inc. (SDIG)
Enfusion, Inc. (ENFN)
Portillos Inc. (PTLO)
Winc, Inc. (BEV)
The Vita Coco Company, Inc. (COCO)
P10, Inc. (PX)
Ventyx Biosciences, Inc. (VTYX)
Winc, Inc. (WBEV)
Runway Growth Finance Corp (RWAY)
Aris Water Solutions, Inc. (ARIS)
Minerva Surgical, Inc (UTRS)
Xilio Therapeutics, Inc. (XLO)
Informatica Inc. (INFA)
Arteris, Inc. (AIP)
Priced IPO
Mink Therapeutics, Inc. (INKT)
Paragon 28, Inc. (FNA)
Ihs Holding Limited (IHS)
Gitlab Inc. (GTLB)
Lucid Diagnostics, Inc. (LUCD)
Healthcare Triangle (HCTI)
AvidXchange (AVDX)
Cognition Therapeutics, Inc. (CGTX)
Isoplexis Corporation (ISO)
Pyxis Oncology, Inc. (PYXS)
Life Time Group Holdings, Inc. (LTH)
Theseus Pharmaceuticals, Inc. (THRX)
Tricon Residential (TCN)
Volcon (VLCN)
Nuvei (NVEI)
Tdcx, Inc. (TDCX)
First Watch Restaurant Group, Inc. (FWRG)
Exscientia Limited (EXAI)
Warby Parker (WRBY)
Olaplex Holdings Inc. (OLPX)
More companies

Chardan NexTech Acquisition 2 (CNTQU)

Sector - SPAC

Price chart

+2.7%
Return from IPO

Last SPACs News

IPO Profile

About company

They are a blank check company. Their intent is to focus on opportunities in disruptive technologies and leverage the tremendous proprietary deal flow that their Board, executive team and sponsor, Chardan have developed over the past 17 years in the SPAC and investment banking marketplaces. Their focus on disruptive technologies is aligned to the investment expertise, relationships, proprietary deal flow, and connectivity of their management team, Board of Directors, and Chardan. Through their multiple decades of special purpose acquisition company, sector, direct investment, and investment banking advisory experiences, their sponsor and management team receive proprietary access to a tremendous pipeline of disruptive technology investment opportunities. As Chardan’s special purpose acquisition company advisory and principal special purpose acquisition company practices have expanded, their inbound deal flow in technology, among other sectors, has significantly increased as private companies seek out their proprietary expertise. Their pool of prospective target businesses are in the HealthTech and FinTech sectors.
Industry
Blank Checks
CEO CFO
-
Employees Founded
3 2020

Contacts

Address: 17 State Street, 21st Floor New York, Ny 10004

Telephone: (646) 465-9000

Web page: http://www.chardan.com

IPO information

First Trade Date 8/11/2021
Status Priced
Exchange NASDAQ
Lockup Period Expiration .Pro
Quiet Period Expiration .Pro
Old Price Range
-
Share prices ($)

Shares & Volumes

Shares Initial (MM) 10
Shares Revised (MM) 11
Expected offer amount (MM) $100
Realized offer amount(MM) $110

Financial Data (last reporting year)

Market Cap (MM) $125.0
Revenues (MM) $0
Net Income (Loss) (MM) $0

Voting

What do you think will happen with the CNTQU share price after the next 3-6 months? 🔥 (+ 10% or more, flat (+ -10%), -10% or less)

Number of votes: img
Underwriters
Chardan Capital Markets
CO-Managers